Author

Aimin Hui

First Affiliated Hospital of Guangzhou Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

Ningze ZhengiD· 2 shared Chunying CheniD· 1 shared Hao GuiD· 1 shared Lei Zhang· 1 shared Rong Cai· 1 shared Weihao Mai· 1 shared Yingqi XuiD· 1 shared Zhicheng HuangiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ningze ZhengORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Integrated immunopeptidomics and transcriptomics reveal a cancer-restricted non-canonical HLA class I ligandome in medulloblastoma

Ningze Zheng, Yingqi Xu, Weihao Mai, Aimin Hui

bioRxiv · Sep 28, 2026 · PreprintCancer Biology

Cyclic-thiourea ionizable lipids program multilamellar mRNA-LNPs for sustained expression, frozen-storage stability and potent vaccine immunotherapy

Lei Zhang, Zhicheng Huang, Hao Gu, Ningze Zheng, Chunying Chen, Rong Cai, Aimin Hui

This paper introduces a cyclic-thiourea ionizable lipid (HI-62) that forms multilamellar mRNA-LNPs with sustained expression, stability, and potent vaccine immunotherapy effects.

bioRxiv · Sep 9, 2026 · PreprintBioengineering

Aimin Hui · henhao